Established February 2002 to discuss experiences with the AstraZeneca drug Iressa.

This drug is currently in clinical trials for treatment of Non-Small Cell Lung Cancer. It is also available under an expanded use program directly from AstraZeneca: http://www.astrazeneca.com

For many, Iressa offers a new weapon in the fight against Lung Cancer. Iressa is an Epidermal Growth Factor Inhibitor and is designed to slow or reverse tumor growth. Side effects are minimal and include an acne-like rash as well as diarrhea.